Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab in locally advanced cervical cancer
NCT05105672Phase 2Unknown
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Mar 2021
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in cervical neoplasm, sponsored by The Affiliated Hospital of Xuzhou Medical University. Status: unknown.
02
Drugs
sintilimab
03
Conditions
cervical neoplasm
Beyond the preview
Go deeper on NCT05105672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05105672.